(UIS) Unisys - NYSE
Sector: Technology | Industry: Information Technology Services | Exchange: NYSE (USA) | Market Cap: 276m USD | Total Return: -17.3% in 12m
Avg Turnover: 4.04M
EPS Trend: -28.6%
Qual. Beats: 0
Rev. Trend: -80.3%
Qual. Beats: 1
Warnings
Negative Equity with losses - insolvent profile
Interest Coverage Ratio -3.3 is critical
Altman Z'' -4.57 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
No distinct edge detected
Unisys Corporation (NYSE: UIS) is a global information technology solutions provider headquartered in Blue Bell, Pennsylvania. The company operates through three primary business segments: Digital Workplace Solutions (DWS), Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). Its portfolio encompasses managed services, hybrid cloud transformation, and its proprietary ClearPath Forward operating environment for high-volume transaction processing.
The company operates within the IT Consulting & Other Services sub-industry, a sector characterized by high recurring revenue through long-term managed services contracts and multi-year software licensing. Unisys utilizes a business model that integrates specialized hardware-software stacks with professional services, targeting complex sectors including financial services, healthcare, and public sector entities.
For a deeper look into the underlying fundamentals of this micro-cap stock, consider reviewing the comprehensive data available on ValueRay. Investors should note that the ECS segment remains a critical margin driver due to the proprietary nature of its enterprise computing platforms.
- ECS segment revenue cycles drive high-margin software license renewals
- Pension funding status and liability volatility impact free cash flow
- DWS and CA&I margin expansion through delivery automation and AI
- New business pipeline conversion supports long-term revenue growth targets
| Net Income: -346.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.13 > 0.02 and ΔFCF/TA -16.60 > 1.0 |
| NWC/Revenue: 15.01% < 20% (prev 19.57%; Δ -4.56% < -1%) |
| CFO/TA -0.10 > 3% & CFO -177.7m > Net Income -346.1m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.49 > 1.5 & < 3 |
| Outstanding Shares: last quarter (71.8m) vs 12m ago 2.23% < -2% |
| Gross Margin: 28.37% > 18% (prev 28.57%; Δ -0.19% > 0.5%) |
| Asset Turnover: 109.5% > 50% (prev 106.1%; Δ 3.37% > 0%) |
| Interest Coverage Ratio: -3.32 > 6 (EBIT TTM -211.6m / Interest Expense TTM 63.7m) |
| A: 0.17 (Total Current Assets 895.9m - Total Current Liabilities 602.4m) / Total Assets 1.73b |
| B: -1.45 (Retained Earnings -2.51b / Total Assets 1.73b) |
| C: -0.12 (EBIT TTM -211.6m / Avg Total Assets 1.79b) |
| D: -0.15 (Book Value of Equity -300.0m / Total Liabilities 2.02b) |
| Altman-Z'' = -4.57 = D |
| DSRI: 0.86 (Receivables 381.3m/443.6m, Revenue 1.96b/1.95b) |
| GMI: 1.01 (GM 28.57% / 28.37%) |
| AQI: 1.00 (AQ_t 0.43 / AQ_t-1 0.43) |
| SGI: 1.00 (Revenue 1.96b / 1.95b) |
| TATA: -0.10 (NI -346.1m - CFO -177.7m) / TA 1.73b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of June 20, 2026, the stock is trading at USD 3.54 with a total of 1,660,800 shares traded.
Over the past week, the price has changed by -6.84%,
over one month by +17.22%,
over three months by +55.95% and
over the past year by -17.29%.
Unisys has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold UIS.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 5.5 | 55.4% |
P/E Forward = 6.8729
P/S = 0.1409
P/B = 17.3148
P/EG = 0.4583
Revenue TTM = 1.96b USD
EBIT TTM = -211.6m USD
EBITDA TTM = -115.2m USD
Long Term Debt = 724.0m USD (from longTermDebt, last quarter)
Short Term Debt = 13.5m USD (from shortTermDebt, last quarter)
Debt = 793.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 27.8m
Net Debt = 412.9m USD (calculated: Debt 793.1m - CCE 380.2m)
Enterprise Value = 688.5m USD (275.6m + Debt 793.1m - CCE 380.2m)
Interest Coverage Ratio = -3.32 (Ebit TTM -211.6m / Interest Expense TTM 63.7m)
EV/FCF = -3.10x (Enterprise Value 688.5m / FCF TTM -222.0m)
FCF Yield = -32.24% (FCF TTM -222.0m / Enterprise Value 688.5m)
FCF Margin = -11.35% (FCF TTM -222.0m / Revenue TTM 1.96b)
Net Margin = -17.70% (Net Income TTM -346.1m / Revenue TTM 1.96b)
Gross Margin = 28.37% ((Revenue TTM 1.96b - Cost of Revenue TTM 1.40b) / Revenue TTM)
Gross Margin QoQ = 25.71% (prev 33.00%)
Tobins Q-Ratio = 0.40 (Enterprise Value 688.5m / Total Assets 1.73b)
Interest Expense / Debt = 8.03% (Interest Expense 63.7m / Debt 793.1m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -167.2m (EBIT -211.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.49 (Total Current Assets 895.9m / Total Current Liabilities 602.4m)
Debt / Equity = -2.64 (negative equity) (Debt 793.1m / totalStockholderEquity, last quarter -300.0m)
Debt / EBITDA = -3.58 (negative EBITDA) (Net Debt 412.9m / EBITDA -115.2m)
Debt / FCF = -1.86 (negative FCF - burning cash) (Net Debt 412.9m / FCF TTM -222.0m)
Total Stockholder Equity = -276.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -19.37% (Net Income -346.1m / Total Assets 1.73b)
RoE = 125.4% (negative equity) (Net Income TTM -346.1m / Total Stockholder Equity -276.1m)
RoCE = -47.24% (EBIT -211.6m / Capital Employed (Equity -276.1m + L.T.Debt 724.0m))
RoIC = -15.99% (negative operating profit) (NOPAT -167.2m / Invested Capital 1.05b)
WACC = 9.01% (E(275.6m)/V(1.07b) * Re(16.67%) + D(793.1m)/V(1.07b) * Rd(8.03%) * (1-Tc(0.21)))
Discount Rate = 16.67% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 72.17 | Cagr: 2.18%
[DCF] Fair Price = unknown (Cash Flow -222.0m)
EPS Correlation: -28.64 | EPS CAGR: -19.24% | SUE: 0.53 | # QB: 0
Revenue Correlation: -80.28 | Revenue CAGR: -1.49% | SUE: 1.07 | # QB: 1
EPS current Quarter (2026-06-30): EPS=-0.04 | Chg30d=N/A | Revisions=-50% | Analysts=5
EPS next Quarter (2026-09-30): EPS=0.46 | Chg30d=-22.04% | Revisions=-14% | Analysts=5
EPS current Year (2026-12-31): EPS=0.83 | Chg30d=+21.75% | Revisions=+50% | GrowthEPS=-10.3% | GrowthRev=-1.6%
EPS next Year (2027-12-31): EPS=1.20 | Chg30d=+25.77% | Revisions=+50% | GrowthEPS=+43.6% | GrowthRev=+1.8%
[Analyst] Revisions Ratio: -50%